Exane Derivatives’s Trade Desk TTD Stock Holding History

Exane Derivatives’s Portfolio TTD Stock Details TTD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-630	Closed	-$14.3K	–	697
2019 Q2	$14.3K	Sell	630 -730	-54%	-$15.7K	﹤0.01%	439
2019 Q1	$26.9K	Sell	1,360 -8,640	-86%	-$142K	0.01%	365
2018 Q4	$116K	Buy	+10,000	New	+$125K	0.02%	305

Other funds holding TTD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Exane Derivatives's TTD Position: Q3 2019 in Review

Exane Derivatives sold out of Trade Desk (TTD) in Q3 2019, closing a stake of 630 shares — an estimated $14.3K sold.

Exane Derivatives first reported a position in TTD in Q4 2018 and held it in 3 quarters. The position peaked at $116K in Q4 2018. 358 funds tracked by Wall St. Rank hold TTD as of Q3 2019.

Exane Derivatives reported no remaining Trade Desk position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 630 Trade Desk shares in Q3 2019, an estimated $14.3K.
Exane Derivatives first reported a position in Trade Desk in Q4 2018 and held it in 3 quarters.
Exane Derivatives's Trade Desk position peaked at $116K in Q4 2018.
358 funds tracked by Wall St. Rank held Trade Desk as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.